Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05795101
Title TRUDI: TDXD+Durva in HER2+/low IBC (TRUDI)
Acronym TRUDI
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Filipa Lynce, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital RECRUITING Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field